Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in

Kimberly O Cameron1, Bruce A Lefker, Margaret Y Chu-Moyer

  • 1Department of Cardiovascular and Metabolic Diseases, Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA. kimberly.o.cameron@pfizer.com